PFM Health Sciences’s Zai Lab ZLAB Stock Holding History

PFM Health Sciences’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-246,706	Closed	-$6.84M	–	88
2023 Q2	$6.84M	Buy	+246,706	New	+$8.07M	0.27%	67
2022 Q4	–	Sell	-23,612	Closed	-$808K	–	100
2022 Q3	$808K	Buy	+23,612	New	+$1.01M	0.03%	84
2021 Q4	–	Sell	-99,375	Closed	-$10.5M	–	90
2021 Q3	$10.5M	Hold	99,375	–	–	0.31%	61
2021 Q2	$17.6M	Hold	99,375	–	–	0.55%	50
2021 Q1	$13.3M	Sell	99,375 -7,686	-7%	-$1.19M	0.4%	59
2020 Q4	$14.5M	Buy	+107,061	New	+$10.9M	0.51%	62
2020 Q2	–	Sell	-84,387	Closed	-$4.34M	–	87
2020 Q1	$4.34M	Buy	+84,387	New	+$4.4M	0.36%	53
2019 Q2	–	Sell	-157,442	Closed	-$4.65M	–	102
2019 Q1	$4.65M	Buy	+157,442	New	+$4.31M	0.1%	87

Other funds holding ZLAB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PFM Health Sciences's ZLAB Position: Q3 2023 in Review

PFM Health Sciences sold out of Zai Lab (ZLAB) in Q3 2023, closing a stake of 246,706 shares — an estimated $6.84M sold.

PFM Health Sciences first reported a position in ZLAB in Q1 2019 and held it in 8 quarters. The position peaked at $17.6M in Q2 2021. 121 funds tracked by Wall St. Rank hold ZLAB as of Q3 2023.

PFM Health Sciences reported no remaining Zai Lab position as of Q3 2023 after selling out during the quarter.
PFM Health Sciences sold 246,706 Zai Lab shares in Q3 2023, an estimated $6.84M.
PFM Health Sciences first reported a position in Zai Lab in Q1 2019 and held it in 8 quarters.
PFM Health Sciences's Zai Lab position peaked at $17.6M in Q2 2021.
121 funds tracked by Wall St. Rank held Zai Lab as of Q3 2023.

Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.